{
    "2020-05-14": [
        [
            {
                "time": "2020-05-14",
                "original_text": "恒瑞医药获临床试验通知书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "临床试验",
                        "通知书"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "陆股通净卖出13.25亿元（附名单）",
                "features": {
                    "keywords": [
                        "陆股通",
                        "净卖出",
                        "资金流出"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "高瓴创新药赛道布局详解",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "创新药",
                        "投资布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "注射剂一致性评价来了 6000亿元市场生死时速上演",
                "features": {
                    "keywords": [
                        "注射剂",
                        "一致性评价",
                        "市场变化"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "科技板块蠢蠢欲动 防御思维依然不休",
                "features": {
                    "keywords": [
                        "科技板块",
                        "蠢蠢欲动",
                        "防御思维"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "A股最大药企受贿案牵出药品“带金销售”灰色利益链",
                "features": {
                    "keywords": [
                        "受贿案",
                        "带金销售",
                        "灰色利益链"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "注射剂‘降价潮’将开启加速模式",
                "features": {
                    "keywords": [
                        "注射剂",
                        "降价潮",
                        "加速模式"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "注射剂一致性评价：恒瑞、齐鲁、正大天晴领跑",
                "features": {
                    "keywords": [
                        "注射剂",
                        "一致性评价",
                        "恒瑞",
                        "齐鲁",
                        "正大天晴"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "司太立：子公司申报的碘帕醇注射液已获审批通过",
                "features": {
                    "keywords": [
                        "司太立",
                        "碘帕醇注射液",
                        "审批通过"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "恐慌，再度归来！沪指急跌0.96%收2870",
                "features": {
                    "keywords": [
                        "恐慌",
                        "沪指急跌",
                        "市场情绪"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}